Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Revenues	$ 54,310	$ 46,058	$ 106,492	$ 91,474
Operating expenses:
Cost of revenue, excluding depreciation and amortization	30,917	24,996	59,706	48,569
Research and development	2,563	2,088	5,403	5,749
Clinical operations, net	1,921	1,661	3,777	3,125
Sales and marketing	14,253	13,240	28,178	26,240
General and administrative	5,728	7,339	10,935	12,535
Depreciation and amortization	718	220	1,368	421
Total costs and operating expenses	56,100	49,544	109,367	96,639
Income (loss) from operations	(1,790)	(3,486)	(2,875)	(5,165)
Financial income, net	(1,325)	(3,044)	(2,851)	(3,422)
Loss before taxes on income	(465)	(442)	(24)	(1,743)
Income tax expense	76	32	199	197
Net income (loss)	$ (541)	$ (474)	$ (223)	$ (1,940)
Net loss per share:
Earnings Per Share, Basic	$ 0	$ 0	$ 0	$ (0.01)
Earnings Per Share, Diluted	$ 0	$ 0	$ 0	$ (0.01)
Weighted average shares used to compute net loss per share:
Basic	167,532,721	169,148,522	168,098,647	168,997,734
Diluted	167,532,721	169,148,522	168,098,647	168,997,734